These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

110 related articles for article (PubMed ID: 1453074)

  • 41. B cell repertoire for anti-DNA antibody in normal and lupus mice: differential expression of precursor cells for high and low affinity anti-DNA antibodies.
    Tsubata T; Nishikawa S; Katsura Y; Kumagai S; Imura H
    Clin Exp Immunol; 1988 Jan; 71(1):50-5. PubMed ID: 3258204
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Constitutive expression of IL-6 receptors and their role in the excessive B cell function in patients with systemic lupus erythematosus.
    Nagafuchi H; Suzuki N; Mizushima Y; Sakane T
    J Immunol; 1993 Dec; 151(11):6525-34. PubMed ID: 8245483
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Monoclonal anti-double-stranded DNA antibodies cross-react with phosphoglycerate kinase 1 and inhibit the expression and production of IL-2 in activated Jurkat T cell line.
    Luan HY; Tang SJ; Yang W; Tsai CY; Sun GH; Sun KH
    Clin Immunol; 2006 Sep; 120(3):326-34. PubMed ID: 16857429
    [TBL] [Abstract][Full Text] [Related]  

  • 44. [Increased immune reactivity in systemic lupus erythematosus. III. Different in vitro stimulation of lymphocytic populations by mitogenic serum factors (author's transl)].
    Günther W; Diezel W; Meffert H; Sönnichsen N
    Dermatol Monatsschr; 1978 Oct; 164(10):711-4. PubMed ID: 310779
    [No Abstract]   [Full Text] [Related]  

  • 45. [Production of interleukin 1 and interleukin 2 in systemic lupus erythematosus].
    Lin YZ; Hsieh KH
    Taiwan Yi Xue Hui Za Zhi; 1987 Jun; 86(6):657-61. PubMed ID: 3498793
    [No Abstract]   [Full Text] [Related]  

  • 46. Antibodies to DNA--towards an understanding of their origin and pathophysiological impact in systemic lupus erythematosus.
    Rekvig OP; Andreassen K; Moens U
    Scand J Rheumatol; 1998; 27(1):1-6. PubMed ID: 9506871
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Etiopathogenesis of systemic lupus erythematosus].
    Mathian A
    Rev Med Interne; 2007 Dec; 28 Suppl 4():S298-301. PubMed ID: 17964004
    [No Abstract]   [Full Text] [Related]  

  • 48. [Immunological reaction to nuclear antigens in children with systemic lupus erythematosus].
    Levina SG; Ausharipova ShR
    Pediatriia; 1981 Sep; (9):35-7. PubMed ID: 6975464
    [No Abstract]   [Full Text] [Related]  

  • 49. [The metabolic regulation in immune cells and pathogenesis of systemic lupus erythematosus ∼toward new therapeutic applications∼].
    Takeshima Y; Iwasaki Y; Okamura T; Fujio K; Yamamoto K
    Nihon Rinsho Meneki Gakkai Kaishi; 2017; 40(1):12-20. PubMed ID: 28539549
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Defective suppressor T-cell activity in systemic lupus erythematosus.
    Kaufman DB; Bostwick E
    Clin Immunol Immunopathol; 1979 May; 13(1):9-18. PubMed ID: 313297
    [No Abstract]   [Full Text] [Related]  

  • 51. Sex steroid hormones and systemic lupus erythematosus.
    Talal N
    Arthritis Rheum; 1981 Aug; 24(8):1054-6. PubMed ID: 6974552
    [No Abstract]   [Full Text] [Related]  

  • 52. Suppressor T-cell abnormality in idiopathic systemic lupus erythematosus.
    Abdou NI; Sagawa A; Pascual E; Hebert J; Sadeghee S
    Clin Immunol Immunopathol; 1976 Sep; 6(2):192-9. PubMed ID: 1085685
    [No Abstract]   [Full Text] [Related]  

  • 53. [Physiopathology and molecular mechanism involving systemic lupus erythematosus].
    Takeuchi T
    Nihon Naika Gakkai Zasshi; 2002 Sep; 91 Suppl():249-55. PubMed ID: 12580125
    [No Abstract]   [Full Text] [Related]  

  • 54. Self Ig peptides: key players in sustaining autoimmunity to dsDNA.
    Reichlin M
    Lupus; 1998; 7(5):293-4. PubMed ID: 9696131
    [No Abstract]   [Full Text] [Related]  

  • 55. Systemic lupus erythematosus in 2015: Cellular and metabolic requirements of effector T cells.
    Tsokos GC
    Nat Rev Rheumatol; 2016 Feb; 12(2):74-6. PubMed ID: 26729463
    [No Abstract]   [Full Text] [Related]  

  • 56. Dehydroepiandrosterone (DHEA) and lupus erythematosus: an update.
    Lahita RG
    Lupus; 1997; 6(6):491-3. PubMed ID: 9256304
    [No Abstract]   [Full Text] [Related]  

  • 57. Cytokines in the pathophysiology of systemic lupus erythematosus.
    Goldman M
    Autoimmunity; 1990; 8(2):173-9. PubMed ID: 2104189
    [No Abstract]   [Full Text] [Related]  

  • 58. Polyoma induced autoimmunity to DNA; experimental systems and clinical observations in human SLE.
    Rekvig O
    Lupus; 1997; 6(3):325-6. PubMed ID: 9296778
    [No Abstract]   [Full Text] [Related]  

  • 59. Dehydroepiandrosterone in the treatment of systemic lupus erythematosus.
    van Vollenhoven RF
    Rheumatology (Oxford); 2000 Aug; 39(8):929-30. PubMed ID: 10952759
    [No Abstract]   [Full Text] [Related]  

  • 60. [Immune disorder in internal medicine].
    Suzuki H
    Nihon Naika Gakkai Zasshi; 1987 Jul; 76(7):1003-9. PubMed ID: 3500245
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.